PCMC
VNDA icon

Planning Capital Management Corporation’s Vanda Pharmaceuticals VNDA Stock Holding History

Planning Capital Management Corporation’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$47 Hold
10
– – ﹤0.01% 747
2024
Q2 		$57 Buy
+10
New +$52 ﹤0.01% 679

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Planning Capital Management Corporation's VNDA Position: Q3 2024 in Review

Planning Capital Management Corporation held its Vanda Pharmaceuticals (VNDA) position steady in Q3 2024 at 10 shares worth $47. The position accounts for ﹤0.01% of the portfolio, ranked #747.

Planning Capital Management Corporation first reported a position in VNDA in Q2 2024 and has held it in 2 quarters since. The position peaked at $57 in Q2 2024. 152 funds tracked by Wall St. Rank hold VNDA as of Q3 2024.

  • Planning Capital Management Corporation held 10 shares of Vanda Pharmaceuticals worth $47 as of Q3 2024.
  • Planning Capital Management Corporation left its Vanda Pharmaceuticals share count unchanged in Q3 2024.
  • Vanda Pharmaceuticals made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #747 holding.
  • Planning Capital Management Corporation first reported a position in Vanda Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • Planning Capital Management Corporation's Vanda Pharmaceuticals position peaked at $57 in Q2 2024.
  • 152 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.